NCT03000933View on ClinicalTrials.gov

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Human PapillomavirusHuman Papillomavirus Infection
Trial Locations (1)

3053

Melbourne Sexual Health Centre, Melbourne

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

The Alfred

OTHER

NCT03000933 - Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2) | Biotech Hunter | Biotech Hunter